VP, Commercial Operations
Quick Summary
Kyverna Therapeutics is a patient-centered, clinical-stage biopharmaceutical company developing cell therapies for patients suffering from autoimmune diseases.
Kyverna Therapeutics is a patient-centered, clinical-stage biopharmaceutical company developing cell therapies for patients suffering from autoimmune diseases. Guided by our core values — Stay True to Why, Collaborate to Accelerate, Lead with Clarity, Boldly Innovative, and Own the Outcome — we are committed to transforming the future of treatment for autoimmune disease. Join us at the forefront of cell therapy innovation and help redefine what’s possible.
Nice to Have
~1 min readKyverna is seeking a strategic and execution-oriented Vice President, Commercial Operations to build and lead a world-class commercial operations organization supporting the launch and commercialization of innovative cell therapies for autoimmune diseases.
As part of the Commercial Leadership Team, the VP will be responsible for developing scalable commercial infrastructure, analytics, forecasting, field operations, CRM, incentives, data strategy, market insights, and operational excellence across the commercial organization. The ideal candidate brings extensive experience leading commercial operations in biotechnology, including launch preparation, specialty therapeutics, cell therapy products, buy-and-bill reimbursement models, and complex patient journeys. Experience supporting autoimmune, neurology, CAR-T, rare disease, or specialty biologics launches is strongly preferred.
The national salary range for this position is $300K to $340K USD annually. This salary range is an estimate of what we reasonably expect to pay for this position, and the actual salary may vary based on factors including experience, education, geographic location, internal equity, and market data. This position is also eligible for annual bonus, equity, benefits, and participation in the Company’s stock plan.
Location & Eligibility
Listing Details
- Posted
- May 16, 2026
- First seen
- May 16, 2026
- Last seen
- May 18, 2026
Posting Health
- Days active
- 0
- Repost count
- 0
- Trust Level
- 68%
- Scored at
- May 16, 2026
Signal breakdown

Kyverna Therapeutics is a biopharmaceutical company focused on developing innovative CAR T-cell therapies for autoimmune diseases.
View company profilePlease let Kyverna know you found this job on Jobera.
3 other jobs at Kyverna
View all →Explore open roles at Kyverna.
Similar Commercial Operations jobs
View all →Browse Similar Jobs
Stay ahead of the market
Get the latest job openings, salary trends, and hiring insights delivered to your inbox every week.
No spam. Unsubscribe at any time.